Title : The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.

Pub. Date : 2012 Jun

PMID : 21989330






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer. Lapatinib cyclin D1 Homo sapiens
2 The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer. Lapatinib cyclin D1 Homo sapiens